tirofiban has been researched along with Purpura, Thrombocytopenic, Idiopathic in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ahmad, S; Fareed, J; Hoppensteadt, DA; Ma, Q; Messmore, HL; Schultz, CL; Untch, B; Walenga, JM | 1 |
Dunkley, S; Evans, S; Gaudry, L; Jepson, N | 1 |
2 other study(ies) available for tirofiban and Purpura, Thrombocytopenic, Idiopathic
Article | Year |
---|---|
Development of a non-human primate sub-clinical model of heparin-induced thrombocytopenia: platelet responses to human anti-heparin-platelet factor 4 antibodies.
Topics: Abciximab; Animals; Antibodies, Monoclonal; Antibody Specificity; Autoantibodies; Blood Platelets; Eptifibatide; Heparin; Humans; Immunoglobulin Fab Fragments; Macaca mulatta; Models, Animal; Peptides; Phylogeny; Plasmapheresis; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Factor 4; Platelet Glycoprotein GPIIb-IIIa Complex; Purpura, Thrombocytopenic, Idiopathic; Serotonin; Species Specificity; Tirofiban; Tyrosine | 2002 |
Two distinct subgroups of tirofiban-induced thrombocytopenia exist due to drug dependent antibodies that cause platelet activation and increased ischaemic events.
Topics: Acute Disease; Aged; Aged, 80 and over; Autoantibodies; Coronary Disease; Female; Humans; Male; Middle Aged; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Purpura, Thrombocytopenic, Idiopathic; Tirofiban; Tyrosine | 2005 |